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Two strikes lead to leukemia
 
New genetic mapping studies explain 
why a certain mouse strain is predisposed 
to developing fatal leukemia. Turcotte et 
al., reporting on page 881, identify a 
point mutation in the transcription factor 
IRF-8 (interferon regulatory factor 8) 
that abolishes its function and sets the 
stage for a second, leukemia-triggering 
mutation.
The recombinant mouse strain BXH-2 is 
known to develop first a myeloproliferative 
disease characterized by enlarged spleens 
with excess granulocytes, and later a 
 
Defenseless against the common cold
 
Epithelial cell dysfunction may explain why people with
asthma fare worse than most when infected with common
cold viruses. Wark and colleagues show on page 937 that
bronchial epithelial cells from asthma sufferers fail to invoke
critical antiviral defenses but still provoke inflammation when
infected with rhinoviruses—an ideal combination for asthma
induction.
Respiratory virus infections often trigger asthma attacks, and
these infections are more severe in asthma sufferers than in
healthy individuals. Past studies have demonstrated increased vi-
rus replication in asthmatic versus healthy subjects and suggested
that alterations in cytokine production that favor asthma-
promoting T helper (Th)-2 responses might be to blame.
Wark and colleagues now uncover a defect that may pro-
vide the initial trigger for virus-induced asthma. They
found that bronchial epithelial cells—the primary targets of
 
spontaneous, fatal myeloid leukemia. The 
myeloproliferative disease is associated 
with a mutation at the 
 
Myls
 
 locus on 
chromosome 8, and the leukemia with 
insertion of an endogenous murine 
leukemia virus (MuLV) into host tumor 
suppressor genes.
The offending virus arises from a 
recombination event between two 
innocuous MuLV proviruses; they are 
carried in the genome of BXH mice but, 
before recombination, cannot produce 
replicating virus progeny. Eager to 
understand how the viral integration 
event was connected to the 
 
Myls
 
 locus, 
Turcotte and colleagues scoured the 
locus for genetic clues. Their search 
revealed an inactivating point mutation 
in IRF-8, a transcription factor that 
regulates interferon-responsive genes. 
The mutation was found only in strains 
that are susceptible to getting leukemia.
The IRF-8 mutation explained the 
myeloproliferative disease in the BXH-2 
mice, as IRF-8–deficient mice were 
previously shown to have a similar 
phenotype. IRF-8–deficient mice also 
develop leukemia, but it is not as rapid 
or as severe as in BXH-2 mice, perhaps 
because these strains lack the MuLV 
proviruses. The authors think that the 
absence of IRF-8 is only the first hit in 
leukemia development. The excess cell 
division and faulty immune response 
caused by the loss of IRF-8, they 
suggest, must promote recombination 
that generates a replication-competent 
MuLV retrovirus that can then insert 
into the host genome.
This may be a good model for human 
chronic myeloid leukemia (CML), which 
progresses from a chronic phase 
involving granulocytes to a rapidly fatal 
crisis stage. The authors are now looking 
for the homologue of IRF-8 in human 
CML tumors.
A mutation in IRF-8 causes myeloproliferation in the spleen which predisposes BXH-2 
mice to leukemia.
 
viral infection—from asthma sufferers supported more virus
replication than did cells from healthy controls. The reason
for this was twofold: epithelial cells from asthmatic subjects
failed to produce the potent anti-viral cytokine interferon-
 
 
 
(IFN-
 
 
 
) and also failed to initiate apoptosis, mechanisms
employed by healthy cells to limit virus replication and elimi-
nate infected cells. These defects may be linked, as IFN-
 
 
 
 was
recently shown to induce apoptosis in virus-infected cells.
How does this enhanced viral replication lead to asthma?
The authors show that epithelial cells from asthma sufferers,
although unable to produce IFN-
 
 
 
, could still secrete pro-
inflammatory cytokines, which can recruit asthma-inducing
eosinophils and Th2 cells to the lungs. Future experiments
are planned to identify the mutation that causes the IFN-
 
 
 
defect. Although several genetic markers have been linked to
asthma in the past, so far none are related to IFNs.
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Clean living staves off 
autoimmunity
 
Autoreactive T cells are harmless until they are 
prodded into action by exposure to common 
microbes, according to Yoshitomi and 
colleagues on page 949. These results may
help explain the contribution of environmental 
factors to human autoimmune diseases like 
rheumatoid arthritis and diabetes.
While studying an arthritis-prone strain of 
mouse, Yoshitomi et al. noted that these mice 
did not develop disease when housed in a 
microbe-free environment, despite the presence 
of T cells that could induce arthritis when 
transferred to nude mice. Only when mice were 
moved to nonsterile conditions (where they 
acquired fungal infections) or were injected 
with 
 
 
 
-glucans from fungal cell walls did the 
telltale symptoms of arthritis appear. Treatment 
of the mice with antifungal drugs or antibodies 
that blocked binding of 
 
 
 
-glucans to cells 
reversed this effect, suggesting a direct link 
between exposure to fungi and development 
of disease.
The same fungal products that triggered 
arthritis stimulated dendritic cells (DCs), the cells 
responsible for activating T cells, to upregulate 
costimulatory molecules and secrete cytokines. 
The authors suspect that 
 
 
 
-glucans, detectable 
in the circulation during infection, reach the local 
lymph nodes where they prompt DCs to activate 
autoreactive T cells. Once activated, the T cells 
invade the joints. The group now plans to 
investigate possible defects in regulatory T cells
in this model, as these cells normally keep 
autoreactive T cells in check.
Fungal infections trigger arthritis in susceptible SKG 
mice (arrowheads indicate fungal spores in the lung).
 
Too old to help
 
Old mice have reduced CD4
 
 
 
 T cell function but, according to new data
from Haynes and colleagues (page 845), the elderly environment is not
to blame. Newly generated T cells functioned normally in elderly mice,
suggesting that strategies to boost T cell production might be an effective
way to improve vaccine efficacy in the elderly.
Previous work by this group has shown that age-related defects
in antibody production result from declining CD4
 
 
 
 T cell help, not
from faulty B cells. By depleting the existing pool of CD4
 
 
 
 T cells
and forcing the thymus to churn out a fresh supply, the authors show
that newly generated CD4
 
 
 
 T cells are equally responsive to antigen
whether they are produced in a young or an old mouse. This suggests
that their functional demise depended on the age of the individual T
cell, not on the age of the mouse.
Although there were no detectable phenotypic differences between old
and young T cells, the authors postulate that unknown defects accumulate
in T cells as they divide and age in the periphery. In young mice, the new
T cells produced by the thymus compensate for the reduced function of their
elderly predecessors. But thymic output decreases with age, and eventually
old T cells outnumber young ones, causing overall T cell function to decline.
Production of B cells, by contrast, does not decrease as drastically with age,
which may explain why B cells are more resistant to the effects of aging.
Although the nature of the defects that accumulate in aging T cells are
not known, recent studies showing an age-related decrease in immune
synapse formation between T cells and antigen presenting cells point to
potential alterations in plasma membrane components. Haynes suggests
that changes in the lipid composition of the plasma membrane—possibly
resulting from routine oxidative stress—may make the membranes less
fluid and slow down the movement of key signaling molecules into the
immune synapse.
CD4  T cells accumulate functional defects as they age. (T cell image provided by 
Michael Dustin, New York University, NY, NY.)
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